Home
Data
Jobs
Companies
Sponsors
About
Home
Data
Jobs
Companies
Sponsors
About
Subscribe
Sign in
Latest
Top
Discussions
BK Virus M&A, Finerenone At ERA, CAR-T Used In Transplant, Vera's IgAN Approval, & Two Bipartisan Bills for Kidney Patients
Your monthly collection of news, research, and commentary shaping the future of kidney and cardiometabolic health
Jul 8
•
Tim Fitzpatrick
1
5:37
June 2026
Alport Syndrome's Next Chapter
Lisa Bonebrake of Alport Syndrome Foundation on genetic testing, patient-powered research, and the push to build a clearer path toward approved…
Jun 28
•
Tim Fitzpatrick
5
2
1
34:39
Part 3: Following the Spend
Why kidney care became the proving ground for healthcare's trillion-dollar accountability transition.
Jun 21
•
Tim Fitzpatrick
and
Janis Naeve
5
1
Why Kidney Breakthroughs Need Shared Infrastructure
How NURTuRE is linking samples, data, and patient participation for the next era of kidney discovery.
Jun 14
•
Gaia Cantelli
5
Inside Dallas Renal Group’s AI Rollout
Dallas Renal Group, Michigan Kidney, and Confido Health discuss what it takes to move AI from early pilots into real patient access workflows across…
Jun 11
•
Tim Fitzpatrick
1
52:55
May 2026
Brief: Can Medicare Help More Patients Stay on Home Dialysis?
H.R. 8875 would create targeted payments for in-home support during the most fragile phase of the home dialysis journey. But is it enough?
May 28
•
Tim Fitzpatrick
7
1
1
Early Warning: FSGS Approval, Biogen's Kidney Push, Cardiac Risk Scores, 50 Years of Transplant Data, & AI at the Front Door
Your monthly collection of news, research, and commentary shaping the future of kidney and cardiometabolic health
May 17
•
Tim Fitzpatrick
5
25:58
Redefining Success in Transplant Medicine
The case for patient-reported outcomes, coordinated advocacy, and new endpoints in transplant drug development
May 3
•
Tim Fitzpatrick
2
39:17
April 2026
Addressing The Pediatric Gap in Kidney Care
From CAKUT to clinical trials, a closer look at the gaps, the science, and the push to close them
Apr 26
•
Tim Fitzpatrick
8
Part 2: The Spaces Between
Why the biggest opportunities in kidney and cardiometabolic health lie in the connections the system was never designed to complete, and in the bridges…
Apr 21
•
Tim Fitzpatrick
and
Janis Naeve
5
3
2
Inside the RPA's Leadership Development Program
Three early-career nephrologists reflect on the 2025 RPA Leadership Development Program and what it shows about advocacy, leadership, and practicing…
Apr 12
•
Tim Fitzpatrick
6
25:37
Part 1: The Canary in the Coal Mine
Why kidney disease is the most important, and most overlooked, signal in American medicine
Apr 8
•
Tim Fitzpatrick
and
Janis Naeve
11
3
4
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts